National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

R-CHOP regimen
An immunochemotherapy regimen consisting of rituximab, cyclophosphamide, hydroxydaunorubicin hydrochloride (doxorubicin hydrochloride), vincristine (Oncovin) and prednisone used to treat both indolent and aggressive forms of non-Hodgkin lymphoma. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Rituximab-Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone regimen



Previous:quinine, Quixin, Qvar, R(+)XK469, R-(-)-gossypol acetic acid
Next:R-flurbiprofen, racemic XK469, RadiaPlex Rx Gel, Raf kinase inhibitor XL281, raloxifene

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov